Literature DB >> 10454405

Stable chronic obstructive pulmonary disease.

H A Kerstjens1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10454405      PMCID： PMC1116389          DOI： 10.1136/bmj.319.7208.495

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  38 in total

1.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock; P Littlejohns
Journal:  Am Rev Respir Dis       Date:  1992-06

2.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

3.  Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.

Authors:  D C Weir; R I Gove; A S Robertson; P S Burge
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

4.  In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.

Authors: 
Journal:  Chest       Date:  1994-05       Impact factor: 9.410

Review 5.  The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  G T O'Connor; D Sparrow; S T Weiss
Journal:  Am Rev Respir Dis       Date:  1989-07

6.  The use of beta-agonists and the risk of death and near death from asthma.

Authors:  W O Spitzer; S Suissa; P Ernst; R I Horwitz; B Habbick; D Cockcroft; J F Boivin; M McNutt; A S Buist; A S Rebuck
Journal:  N Engl J Med       Date:  1992-02-20       Impact factor: 91.245

7.  Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis.

Authors:  C M Callahan; R S Dittus; B P Katz
Journal:  Ann Intern Med       Date:  1991-02-01       Impact factor: 25.391

8.  A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.

Authors:  S R Braun; W N McKenzie; C Copeland; L Knight; M Ellersieck
Journal:  Arch Intern Med       Date:  1989-03

9.  Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis.

Authors:  B G Higgins; R M Powell; S Cooper; A E Tattersfield
Journal:  Eur Respir J       Date:  1991-04       Impact factor: 16.671

10.  Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.

Authors:  C P van Schayck; E Dompeling; C L van Herwaarden; H Folgering; A L Verbeek; H J van der Hoogen; C van Weel
Journal:  BMJ       Date:  1991-12-07
View more
  3 in total

1.  Stable chronic obstructive pulmonary disease. Incomplete evidence based reviews may condemn by omission.

Authors:  M C Steiner; S Singh; M D Morgan
Journal:  BMJ       Date:  2000-01-29

Review 2.  Budesonide/formoterol: in chronic obstructive pulmonary disease.

Authors:  Neil A Reynolds; Caroline M Perry; Gillian M Keating
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease.

Authors:  Katherine E Lowe; Elizabeth A Regan; Antonio Anzueto; Erin Austin; John H M Austin; Terri H Beaty; Panayiotis V Benos; Christopher J Benway; Surya P Bhatt; Eugene R Bleecker; Sandeep Bodduluri; Jessica Bon; Aladin M Boriek; Adel Re Boueiz; Russell P Bowler; Matthew Budoff; Richard Casaburi; Peter J Castaldi; Jean-Paul Charbonnier; Michael H Cho; Alejandro Comellas; Douglas Conrad; Corinne Costa Davis; Gerard J Criner; Douglas Curran-Everett; Jeffrey L Curtis; Dawn L DeMeo; Alejandro A Diaz; Mark T Dransfield; Jennifer G Dy; Ashraf Fawzy; Margaret Fleming; Eric L Flenaugh; Marilyn G Foreman; Spyridon Fortis; Hirut Gebrekristos; Sarah Grant; Philippe A Grenier; Tian Gu; Abhya Gupta; MeiLan K Han; Nicola A Hanania; Nadia N Hansel; Lystra P Hayden; Craig P Hersh; Brian D Hobbs; Eric A Hoffman; James C Hogg; John E Hokanson; Karin F Hoth; Albert Hsiao; Stephen Humphries; Kathleen Jacobs; Francine L Jacobson; Ella A Kazerooni; Victor Kim; Woo Jin Kim; Gregory L Kinney; Harald Koegler; Sharon M Lutz; David A Lynch; Neil R MacIntye; Barry J Make; Nathaniel Marchetti; Fernando J Martinez; Diego J Maselli; Anne M Mathews; Meredith C McCormack; Merry-Lynn N McDonald; Charlene E McEvoy; Matthew Moll; Sarah S Molye; Susan Murray; Hrudaya Nath; John D Newell; Mariaelena Occhipinti; Matteo Paoletti; Trisha Parekh; Massimo Pistolesi; Katherine A Pratte; Nirupama Putcha; Margaret Ragland; Joseph M Reinhardt; Stephen I Rennard; Richard A Rosiello; James C Ross; Harry B Rossiter; Ingo Ruczinski; Raul San Jose Estepar; Frank C Sciurba; Jessica C Sieren; Harjinder Singh; Xavier Soler; Robert M Steiner; Matthew J Strand; William W Stringer; Ruth Tal-Singer; Byron Thomashow; Gonzalo Vegas Sánchez-Ferrero; John W Walsh; Emily S Wan; George R Washko; J Michael Wells; Chris H Wendt; Gloria Westney; Ava Wilson; Robert A Wise; Andrew Yen; Kendra Young; Jeong Yun; Edwin K Silverman; James D Crapo
Journal:  Chronic Obstr Pulm Dis       Date:  2019-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.